PHARMING GROUP NV (PHARM.AS)
NL0010391025 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.01M | 14.99M | 23.08M | 44.09M | 49.50M | |||
| Depreciation Amortization | 15.93M | 13.19M | 19.61M | 8.31M | 5.49M | |||
| Change In Working Capital | -14.73M | -1.54M | -4.91M | -5.86M | -3.57M | |||
| Interest Paid | 4.05M | 3.95M | 4.45M | 2.14M | 8.93M | |||
| Taxes Paid | 655.00K | 1.24M | 0.00 | 2.66M | 5.41M | |||
| Other non cash items | -6.48M | -4.18M | 62.00K | 37.08M | 19.10M | |||
| OPERATING CASH FLOW | -17.30M | 22.46M | 37.84M | 83.63M | 70.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.46M | -1.98M | -16.72M | -15.30M | -24.09M | |||
| Other Investing Activity | -127.92M | 7.30M | -4.59M | -329.00K | -2.65M | |||
| INVESTING CASH FLOW | -129.39M | 5.32M | -21.30M | -15.63M | -26.74M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.13M | -3.31M | -3.22M | 83.41M | -35.39M | |||
| Stock Issued/Repurchased | 8.13M | 2.28M | 4.72M | 2.79M | 2.95M | |||
| Other Financing Activity | -4.05M | -3.95M | -29.45M | -25.51M | -27.63M | |||
| FINANCING CASH FLOW | -1.04M | -4.98M | -27.95M | 60.69M | -60.07M | |||
| Exchange Rate Effect | 2.13M | -7.38M | -1.82M | 2.13M | 1.43M | |||
| CHANGE IN CASH | -145.60M | 15.42M | -13.23M | 130.81M | -14.86M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.30M | 22.46M | 37.84M | 83.63M | 70.53M | |||
| Capital Expenditure | -1.46M | -1.98M | -16.72M | -15.30M | -24.09M | |||
| FREE CASH FLOW | -18.77M | 20.48M | 21.13M | 68.33M | 46.44M | |||
All data in USD